158 related articles for article (PubMed ID: 35261272)
21. MDM2 FISH testing criteria in adipose tissue tumors with mature adipocytic morphology - A resection case-based study.
Li L; Yue P; Du Q; Zhang H; Song Y
Pathol Res Pract; 2024 Jan; 253():155039. PubMed ID: 38134838
[TBL] [Abstract][Full Text] [Related]
22. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization for the Evaluation of MDM2 Amplification in Adipocytic Tumors.
Mardekian SK; Solomides CC; Gong JZ; Peiper SC; Wang ZX; Bajaj R
J Clin Lab Anal; 2015 Nov; 29(6):462-8. PubMed ID: 25132285
[TBL] [Abstract][Full Text] [Related]
24. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
26. Clinical Application of Chromosome Microarray Analysis in the Diagnosis of Lipomatous Tumors.
Pei J; Flieder DB; Talarchek JN; Cooper HS; Patchefsky AS; Wei S
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):592-598. PubMed ID: 33734108
[TBL] [Abstract][Full Text] [Related]
27. Dysplastic lipoma: potential diagnostic pitfall of using MDM2 RNA in situ hybridization to distinguish between lipoma and atypical lipomatous tumor.
Hung YP; Michal M; Dubuc AM; Rosenberg AE; Nielsen GP
Hum Pathol; 2020 Jul; 101():53-57. PubMed ID: 32439322
[TBL] [Abstract][Full Text] [Related]
28. Automated Bright-Field Dual-Color In Situ Hybridization for MDM2: Interobserver Reproducibility and Correlation With Fluorescence In Situ Hybridization in a Series of Soft Tissue Consults.
Zhang G; Lanigan CP; Goldblum JR; Tubbs RR; Downs-Kelly E
Arch Pathol Lab Med; 2016 Oct; 140(10):1111-5. PubMed ID: 27684983
[TBL] [Abstract][Full Text] [Related]
29. Lessons learnt from MDM2 fluorescence in-situ hybridisation analysis of 439 mature lipomatous lesions with an emphasis on atypical lipomatous tumour/well-differentiated liposarcoma lacking cytological atypia.
Vargas AC; Joy C; Cheah AL; Jones M; Bonar F; Brookwell R; Garrone B; Talbot J; Harraway J; Gill AJ; Maclean FM
Histopathology; 2022 Jan; 80(2):369-380. PubMed ID: 34523152
[TBL] [Abstract][Full Text] [Related]
30. Overexpression and amplification of Murine double minute 2 as a diagnostic tool in large lipomatous tumor and its correlation with Ki67 proliferation index: an institutional experience.
Putri RI; Siregar NC; Siregar B
Indian J Pathol Microbiol; 2014; 57(4):558-63. PubMed ID: 25308007
[TBL] [Abstract][Full Text] [Related]
31. MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification.
Brisson M; Kashima T; Delaney D; Tirabosco R; Clarke A; Cro S; Flanagan AM; O'Donnell P
Skeletal Radiol; 2013 May; 42(5):635-47. PubMed ID: 22987247
[TBL] [Abstract][Full Text] [Related]
32. p16 Expression in Fat Necrosis: A Potential Diagnostic Pitfall in the Evaluation of Differentiated Adipocytic Neoplasms.
Ng W; Messiou C; Smith M; Thway K
Int J Surg Pathol; 2015 Oct; 23(7):544-8. PubMed ID: 26173427
[TBL] [Abstract][Full Text] [Related]
33. Biology and Management of Deep-seated Atypical Lipomatous Tumor of the Extremities.
Nishio J; Nakayama S; Chijiiwa Y; Aoki M
Anticancer Res; 2023 Oct; 43(10):4295-4301. PubMed ID: 37772567
[TBL] [Abstract][Full Text] [Related]
34. MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria.
Clay MR; Martinez AP; Weiss SW; Edgar MA
Am J Surg Pathol; 2015 Oct; 39(10):1433-9. PubMed ID: 26146760
[TBL] [Abstract][Full Text] [Related]
35. FISH Diagnostic Assessment of
Gambella A; Bertero L; Rondón-Lagos M; Verdun Di Cantogno L; Rangel N; Pitino C; Ricci AA; Mangherini L; Castellano I; Cassoni P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674856
[No Abstract] [Full Text] [Related]
36. Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma.
Creytens D; van Gorp J; Savola S; Ferdinande L; Mentzel T; Libbrecht L
Virchows Arch; 2014 Jul; 465(1):97-108. PubMed ID: 24659226
[TBL] [Abstract][Full Text] [Related]
37. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
[TBL] [Abstract][Full Text] [Related]
38. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors.
Zhang H; Erickson-Johnson M; Wang X; Oliveira JL; Nascimento AG; Sim FH; Wenger DE; Zamolyi RQ; Pannain VL; Oliveira AM
Am J Surg Pathol; 2010 Sep; 34(9):1304-11. PubMed ID: 20679883
[TBL] [Abstract][Full Text] [Related]
39. Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the "missing link" between lipomas and liposarcomas?
Italiano A; Cardot N; Dupré F; Monticelli I; Keslair F; Piche M; Mainguené C; Coindre JM; Pedeutour F
Int J Cancer; 2007 Jul; 121(2):308-15. PubMed ID: 17372913
[TBL] [Abstract][Full Text] [Related]
40. Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas.
Zhang W; McElhinny A; Nielsen A; Wang M; Miller M; Singh S; Rueger R; Rubin BP; Wang Z; Tubbs RR; Nagle RB; Roche P; Wu P; Pestic-Dragovich L
Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):54-61. PubMed ID: 20881839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]